MyCelx Technologies AI Stock Analysis
Want to see GB:MYX full AI Analyst Report?
MyCelx Technologies (MYX) AI Stock Analysis
MyCelx Technologies
(LSE:MYX)
The overall score reflects a business that has moved back to profitability with improving revenue but still faces significant risk from negative operating and free cash flow, supported by a modestly leveraged balance sheet and only moderate, non-overbought technical momentum. Valuation appears reasonable rather than clearly cheap, with a mid-range P/E and no evident dividend support, leading to a cautiously neutral-to-constructive outlook rather than a high-conviction opportunity.
MyCelx Technologies (MYX) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 11.21M
- Dividend Yield
- ―
- Average Volume (3M)
- 26.76K
- Price to Earnings (P/E)
- 20.5
- Beta (1Y)
- 0.23
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- UK
- Employees
- 18
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Industrial - Pollution & Treatment Controls
MyCelx Technologies Business Overview & Revenue Model
Company Description
MYCELX Technologies Corporation is a clean water technology firm that provides water purification systems to a wide array of industries, including the petroleum, power generation, maritime, and heavy manufacturing sectors. The company operates global...
How the Company Makes Money
MyCelx makes money primarily by selling and deploying its proprietary filtration media and the associated water treatment equipment/systems that use that media. Revenue is generated through (1) product sales of MyCelx filtration media (consumable or...
MyCelx Technologies Financial Statement Overview
Summary
Revenue rebounded to 11.7M in 2025 with a return to net profit and a reasonably stable, low-leverage balance sheet, but earnings remain fragile and operating/free cash flow stayed negative, limiting financial strength.
Income Statement
63PositiveBalance Sheet
68PositiveCash Flow
34Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.18M | 11.74M | 4.90M | 10.91M | 10.03M | 8.48M |
| Gross Profit | 6.15M | 5.62M | 1.34M | 3.89M | 4.44M | 3.27M |
| EBITDA | 1.77M | 1.11M | -2.23M | -2.46M | -2.48M | 19.00K |
| Net Income | 815.00K | 334.00K | -2.72M | -3.71M | -3.99M | -1.43M |
Balance Sheet | ||||||
| Total Assets | 8.77M | 8.67M | 10.05M | 10.39M | 13.62M | 15.66M |
| Cash, Cash Equivalents and Short-Term Investments | 499.00K | 812.00K | 1.26M | 383.00K | 1.65M | 3.13M |
| Total Debt | 1.12M | 1.26M | 1.26M | 889.00K | 1.22M | 1.47M |
| Total Liabilities | 4.52M | 3.01M | 4.79M | 3.23M | 2.79M | 3.04M |
| Stockholders Equity | 4.25M | 5.66M | 5.26M | 7.16M | 10.83M | 12.62M |
Cash Flow | ||||||
| Free Cash Flow | -644.00K | -898.00K | -2.20M | -1.21M | -3.53M | -3.80M |
| Operating Cash Flow | -576.00K | -863.00K | -2.15M | -1.11M | -2.69M | -3.43M |
| Investing Cash Flow | -68.00K | -35.00K | 2.24M | -181.00K | -842.00K | 5.08M |
| Financing Cash Flow | 500.00K | 450.00K | 792.00K | 0 | 2.04M | -2.24M |
MyCelx Technologies Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:MYX, the sentiment is Negative. The current price of 46.00 is below the 20-day moving average (MA) of 46.95, below the 50-day MA of 51.44, and below the 200-day MA of 51.50, indicating a bearish trend. The MACD of -1.51 indicates Negative momentum. The RSI at 31.59 is Neutral, neither overbought nor oversold. The STOCH value of 49.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:MYX.
MyCelx Technologies Peers Comparison
Overall Rating
GB:PRV78Outperform
GB:WATR76Outperform
GB:FLO60Neutral- GB:MYX58Neutral
GB:ITM57Neutral
GB:DIA49Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| GB:PRV | 78Outperform | GBP 402.93M | 21.85 | 10.96% | 0.79% | 3.47% | 10.35% |
| GB:WATR | 76Outperform | GBP 53.26M | 14.38 | 6.10% | ― | 4.01% | -4.27% |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| GB:FLO | 60Neutral | GBP 47.97M | -13.26 | -5.87% | ― | 20.26% | 89.85% |
| GB:MYX | 58Neutral | GBP 11.21M | 20.50 | 16.44% | ― | ― | ― |
| GB:ITM | 57Neutral | GBP 517.86M | -18.46 | -11.09% | ― | 67.62% | 45.05% |
| GB:DIA | 49Neutral | GBP 230.88M | 24.23 | 24.61% | ― | -5.32% | 0.72% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:MYX | MyCelx Technologies | 46.00 | 17.50 | 61.40% | |
| GB:DIA | Dialight plc | 586.00 | 286.00 | 95.33% | |
| GB:FLO | Flowtech Fluidpower | 57.00 | 6.00 | 11.76% | |
| GB:ITM | ITM Power | 71.25 | -6.25 | -8.06% | |
| GB:PRV | Porvair plc | 874.00 | 89.15 | 11.36% | |
| GB:WATR | Water Intelligence | 282.50 | -25.50 | -8.28% |
MyCelx Technologies Corporate Events
MYCELX Delays Revenue to 2027 as Project Slips and Customer Disruption Hit 2026
NegativeMYCELX Technologies has warned that around $2 million of revenue expected for 2026 will now be recognized in 2027 after a major Middle Eastern customer failed to issue a purchase order within the fabrication window, delaying delivery of a significant...
MYCELX Shareholders Back Board, Auditor and Pay at Adjourned AGM
PositiveMYCELX Technologies Corporation reported that all resolutions at its adjourned Annual Meeting on 1 October 2026 in Norcross, Georgia were passed on a poll, including the election of directors Tom Lamb, Connie Mixon, Haluk Alper and Torben Wetche. Sha...
MyCelx Adjourns Annual Meeting After Failing to Reach Quorum
NeutralMyCelx Technologies Corporation opened its Annual Meeting on 17 September 2026 in London, but was forced to adjourn after failing to reach the quorum required under its bylaws, which demand participation from shareholders representing more than 50 pe...
MYCELX Marks Inflection Point as Contract Pipeline Triples on New Oil Major Approval
PositiveMYCELX Technologies Corporation says it has reached a key inflection point after several years of development, with the last eight months bringing a major expansion in its sales opportunity pipeline. The company’s technology has now been approved by...
MyCelx boosts H1 revenue and secures key produced water contracts
PositiveMyCelx Technologies reported a 26% rise in first-half 2026 revenue to $2.1 million, driven by paid trials, equipment leases and recurring media sales that lifted gross margin to 57%, while losses narrowed versus the prior year. Operationally, the gro...
MYCELX Sends 2026 Annual Meeting Notice to Shareholders
NeutralMYCELX Technologies Corporation has mailed the Notice of its 2026 Annual Meeting to shareholders, following the June distribution of its 2025 Annual Report. The notice is available on the company’s website and at its Norcross, Georgia headquarters, e...
MYCELX Targets Strong H2 as Permian and Offshore Water Projects Build Momentum
PositiveMYCELX reported unaudited H1 2026 revenue of about $2.1 million, up from $1.7 million a year earlier, driven by paid trials, leases and recurring media sales. Management expects a significantly stronger second half, underpinned by a $3.9 million REGE...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 09, 2026